KKR and Highland Europe have made a strategic investment in smaXtec, aimed at enhancing the global dairy industry through innovative health management technologies.

Investment Overview

The aim of this investment is to sustainably enhance the dairy industry through innovative technologies and support for global expansion. Today, smaXtec, a leading provider of technological solutions for the global dairy industry, announced a growth investment led by prominent global investment firms KKR and Highland Europe. Existing shareholder Sophora Unternehmerkapital maintains its minority stake in the company. Financial details of the transactions have not been disclosed.

Target Company Information

smaXtec is a pioneering monitoring platform that employs its proprietary technology to help dairy farms increase efficiency and promote animal health. The platform facilitates early disease detection, monitors fertility through estrus detection, and reduces birth-related complications. A key component of smaXtec's innovative product range is the in-vivo bolus, a proprietary sensor that is placed in the stomach of the cow. This sensor provides real-time data with high accuracy and seamlessly connects to a cloud-based, AI-driven analytics platform. Farmers can remotely access data and alerts, enabling proactive management decisions. Founded in 2009 in Graz, Austria, smaXtec now collaborates with farms in Europe, North America, as well as Australia and New Zealand.

Industry Overview

The global dairy industry is undergoing significant transformation as technology continues to reshape farming practices. There is an increasing need for digital solutions that enhance animal health, improve pr